Chandler Park, Kentucky Physician Representative of the ASCO State Executive Council, shared the following on LinkedIn:
“FDA approves practice changing treatment for biochemical recurrence after radical prostatectomy and/or radiation treatment. LOVED discussing this study with national prostate cancer experts Larry Karsh MD and Michael Cookson MD.
Data published in NEJM.”
For details click here.
Source: Chandler Park/Twitter
